203 related articles for article (PubMed ID: 37244352)
1. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
[TBL] [Abstract][Full Text] [Related]
2. Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
Durand MA; Drouin A; Mouchard A; Durand L; Esnault C; Berthon P; Tallet A; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Saiag P; Beneton N; Bens G; Nardin C; Aubin F; Dinulescu M; Collin C; Fromont-Hankard G; Cribier B; Laurent-Roussel S; Cokelaere K; Houben R; Schrama D; Peixoto P; Hervouet E; Bachiri K; Kantar D; Coyaud E; Guyétant S; Samimi M; Touzé A; Kervarrec T
J Invest Dermatol; 2023 Oct; 143(10):1937-1946.e7. PubMed ID: 37037414
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.
Rasheed K; Sveinbjørnsson B; Moens U
Virol J; 2021 Jul; 18(1):139. PubMed ID: 34217322
[TBL] [Abstract][Full Text] [Related]
4. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
Veija T; Kero M; Koljonen V; Böhling T
Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
[TBL] [Abstract][Full Text] [Related]
5. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
6. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.
Houben R; Shuda M; Weinkam R; Schrama D; Feng H; Chang Y; Moore PS; Becker JC
J Virol; 2010 Jul; 84(14):7064-72. PubMed ID: 20444890
[TBL] [Abstract][Full Text] [Related]
9. RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.
Hesbacher S; Pfitzer L; Wiedorfer K; Angermeyer S; Borst A; Haferkamp S; Scholz CJ; Wobser M; Schrama D; Houben R
Oncotarget; 2016 May; 7(22):32956-68. PubMed ID: 27121059
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
[TBL] [Abstract][Full Text] [Related]
11. Merkel Cell Polyomavirus Large T Antigen Unique Domain Regulates Its Own Protein Stability and Cell Growth.
Nwogu N; Ortiz LE; Kwun HJ
Viruses; 2020 Sep; 12(9):. PubMed ID: 32962090
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
13. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma.
Acikalin A; Bagir E; Paydas S
Pol J Pathol; 2021; 72(2):140-147. PubMed ID: 34706521
[TBL] [Abstract][Full Text] [Related]
15. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
[TBL] [Abstract][Full Text] [Related]
16. High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.
Borchert S; Czech-Sioli M; Neumann F; Schmidt C; Wimmer P; Dobner T; Grundhoff A; Fischer N
J Virol; 2014 Mar; 88(6):3144-60. PubMed ID: 24371076
[TBL] [Abstract][Full Text] [Related]
17. Merkel Cell Carcinoma Sensitivity to EZH2 Inhibition Is Mediated by SIX1 Derepression.
Gartin AK; Frost TC; Cushman CH; Leeper BA; Gokhale PC; DeCaprio JA
J Invest Dermatol; 2022 Oct; 142(10):2783-2792.e15. PubMed ID: 35331717
[TBL] [Abstract][Full Text] [Related]
18. Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Nwogu N; Ortiz LE; Whitehouse A; Kwun HJ
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669331
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
Reisinger DM; Shiffer JD; Cognetta AB; Chang Y; Moore PS
J Am Acad Dermatol; 2010 Sep; 63(3):400-3. PubMed ID: 20584559
[TBL] [Abstract][Full Text] [Related]
20. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
Shuda M; Arora R; Kwun HJ; Feng H; Sarid R; Fernández-Figueras MT; Tolstov Y; Gjoerup O; Mansukhani MM; Swerdlow SH; Chaudhary PM; Kirkwood JM; Nalesnik MA; Kant JA; Weiss LM; Moore PS; Chang Y
Int J Cancer; 2009 Sep; 125(6):1243-9. PubMed ID: 19499546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
